Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Private equity
CRO
Private equity firm acquires CRO CenExel
Boston-based BayPine has acquired a majority stake in the company, leaving former majority owner Webster Equity Partners with a minority stake.
Darren Incorvaia
Apr 15, 2025 12:50pm
Blackstone buys majority stake in CMIC, Japan's largest CRO
Mar 4, 2025 2:37pm
Evotec attracts private equity buyout interest: report
Nov 11, 2024 9:17am
Avantor divests clinical services unit for $650M
Aug 19, 2024 4:52pm
Destiny goes private to stay afloat after no partner found
Jul 15, 2024 4:33am
Trial sites 'hottest' pharma services category for PE: PitchBook
Jun 20, 2024 12:01am
